Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
14.28
-0.50 (-3.38%)
At close: Aug 5, 2025, 4:00 PM
14.64
+0.36 (2.52%)
After-hours: Aug 5, 2025, 4:10 PM EDT
Exscientia Market Cap
Seres Therapeutics has a market cap or net worth of $124.70 million as of August 5, 2025. Its market cap has decreased by -34.64% in one year.
Market Cap
124.70M
Enterprise Value
155.40M
1-Year Change
-34.64%
Ranking
Category
Stock Price
$14.28
Market Cap Chart
Since June 26, 2015, Seres Therapeutics's market cap has decreased from $1.88B to $124.70M, a decrease of -93.38%. That is a compound annual growth rate of -23.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 4, 2025 | 129.10M | -9.02% |
Dec 31, 2024 | 141.90M | -21.60% |
Dec 29, 2023 | 181.00M | -74.06% |
Dec 30, 2022 | 697.70M | -8.81% |
Dec 31, 2021 | 765.10M | -65.78% |
Dec 31, 2020 | 2.24B | 825.71% |
Dec 31, 2019 | 241.50M | 30.75% |
Dec 31, 2018 | 184.70M | -55.06% |
Dec 29, 2017 | 411.00M | 2.88% |
Dec 30, 2016 | 399.50M | -70.85% |
Dec 31, 2015 | 1.37B | -27.26% |
Jun 26, 2015 | 1.88B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 684.37B |
Johnson & Johnson | 402.99B |
AbbVie | 344.84B |
AstraZeneca | 228.08B |
Novartis AG | 224.47B |
Abbott Laboratories | 221.54B |
UnitedHealth Group | 215.69B |
Novo Nordisk | 211.90B |